BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18781821)

  • 1. Targeting protein kinase B/Akt signaling with vanadium compounds for cardioprotection.
    Bhuiyan MS; Shioda N; Fukunaga K
    Expert Opin Ther Targets; 2008 Oct; 12(10):1217-27. PubMed ID: 18781821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection by vanadium compounds targeting Akt-mediated signaling.
    Bhuiyan MS; Fukunaga K
    J Pharmacol Sci; 2009 May; 110(1):1-13. PubMed ID: 19423951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression.
    Bhuiyan MS; Shibuya M; Shioda N; Moriguchi S; Kasahara J; Iwabuchi Y; Fukunaga K
    Eur J Pharmacol; 2007 Oct; 571(2-3):180-8. PubMed ID: 17658509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective effect of vanadyl sulfate on ischemia/reperfusion-induced injury in rat heart in vivo is mediated by activation of protein kinase B and induction of FLICE-inhibitory protein.
    Bhuiyan MS; Takada Y; Shioda N; Moriguchi S; Kasahara J; Fukunaga K
    Cardiovasc Ther; 2008; 26(1):10-23. PubMed ID: 18466417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that the MEK/ERK but not the PI3K/Akt pathway is required for protection from myocardial ischemia-reperfusion injury by 3',4'-dihydroxyflavonol.
    Thomas CJ; Lim NR; Kedikaetswe A; Yeap YY; Woodman OL; Ng DC; May CN
    Eur J Pharmacol; 2015 Jul; 758():53-9. PubMed ID: 25820159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
    Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
    Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benefit of vanadium compound in therapy for cardiovascular diseases].
    Fukunaga K
    Yakugaku Zasshi; 2012; 132(3):279-84. PubMed ID: 22382830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ophiopogonin D Reduces Myocardial Ischemia-Reperfusion Injury via Upregulating CYP2J3/EETs in Rats.
    Huang X; Wang Y; Wang Y; Yang L; Wang J; Gao Y
    Cell Physiol Biochem; 2018; 49(4):1646-1658. PubMed ID: 30227401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bis(acetylacetonato)-oxovanadium(iv), bis(maltolato)-oxovanadium(iv) and sodium metavanadate induce antilipolytic effects by regulating hormone-sensitive lipase and perilipin via activation of Akt.
    Liu JC; Yu Y; Wang G; Wang K; Yang XG
    Metallomics; 2013 Jun; 5(7):813-20. PubMed ID: 23576171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
    Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
    Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A labdane diterpene exerts ex vivo and in vivo cardioprotection against post-ischemic injury: involvement of AKT-dependent mechanisms.
    Cuadrado-Berrocal I; Gómez-Gaviro MV; Benito Y; Barrio A; Bermejo J; Fernández-Santos ME; Sánchez PL; Desco M; Fernández-Avilés F; Fernández-Velasco M; Boscá L; de Las Heras B
    Biochem Pharmacol; 2015 Feb; 93(4):428-39. PubMed ID: 25557296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways.
    Xue R; Lei S; Xia ZY; Wu Y; Meng Q; Zhan L; Su W; Liu H; Xu J; Liu Z; Zhou B; Xia Z
    Clin Sci (Lond); 2016 Mar; 130(5):377-92. PubMed ID: 26666444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GYY4137 protects against myocardial ischemia/reperfusion injury via activation of the PHLPP-1/Akt/Nrf2 signaling pathway in diabetic mice.
    Qiu Y; Wu Y; Meng M; Luo M; Zhao H; Sun H; Gao S
    J Surg Res; 2018 May; 225():29-39. PubMed ID: 29605032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting phosphatidylinositol 3-kinase-Akt through hepatocyte growth factor for cardioprotection.
    Madonna R; Bolli R; Rokosh G; De Caterina R
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):249-53. PubMed ID: 22609872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of urantide against ischemia-reperfusion injury via protein kinase C and phosphtidylinositol 3'-kinase - Akt pathway.
    Zhang JY; Chen ZW; Yao H
    Can J Physiol Pharmacol; 2012 May; 90(5):637-45. PubMed ID: 22537485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection of tilianin ameliorates myocardial ischemia-reperfusion injury: Role of the apoptotic signaling pathway.
    Zeng C; Jiang W; Zheng R; He C; Li J; Xing J
    PLoS One; 2018; 13(3):e0193845. PubMed ID: 29538428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.
    Nagaoka K; Matoba T; Mao Y; Nakano Y; Ikeda G; Egusa S; Tokutome M; Nagahama R; Nakano K; Sunagawa K; Egashira K
    PLoS One; 2015; 10(7):e0132451. PubMed ID: 26167913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
    Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
    Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
    Sato T; Tanno M; Miki T; Yano T; Sato T; Shimamoto K; Miura T
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.